Apple Appeals ITC Ban on Apple Watch Sales Over Masimo Patent Dispute

The tech giant is fighting to overturn a ruling that temporarily halted sales of its latest watch models due to a patent infringement claim.

Apple is currently appealing an ITC ruling that banned the sale of Apple Watch Series 9 and Ultra 2 in the U.S. due to a patent dispute with Masimo over blood oxygen sensor technology.
The ban, briefly enforced, has been circumvented by Apple selling modified versions of the watches with the blood oxygen features disabled.
Apple's appeal includes a 900-page brief arguing that the ITC exceeded its authority and made defective patent rulings.
Third-party retailers like Best Buy and Amazon can still sell the Apple Watch Series 9 and Ultra 2 with the blood oxygen app and features.
The outcome of the appeal could impact future cases, as Apple argues the ITC's decision opens the door to complaints from entities lacking an actual domestic industry but possessing creative pleadings.